Literature DB >> 11291950

Role of electroretinography in the assessment of retinal function as an indicator of vitamin A status.

I Tsinopoulos1, S Nousia-Arvanitakis, A Galli-Tsinopoulou, N Roubies, K Tentzidou, M Xefteri, N Stangos.   

Abstract

Hypovitaminosis A is associated with exocrine pancreatic insufficiency in cystic fibrosis. Peripheral retinal dysfunction is an early finding of vitamin A deficiency. We evaluated serum retinol and zinc as well as visual adaptation in 41 patients with cystic fibrosis, receiving generous pancreatic enzyme and micronutrient supplementation. Forty-one normal individuals matched for age and sex served as controls. Peripheral retinal function was measured by clinical electroretinography using an Electrophysiologic Personal Interfaced Computer and applying a standard protocol. Serum retinol in cystic fibrosis was significantly lower than that of the control group (0.30+/-0.01 versus 0.39+/-0.02 mg/l, p<0.001). Serum zinc concentrations were normal in the cystic fibrosis group (1.21+/-0.03 mg/l) and significantly higher than that of the control group (1.02+/-0.01 mg/l, p<0.001). The overall visual adaptation, however, was found to be normal and comparable in the two groups. It is concluded that, in cystic fibrosis, despite appropriate vitamin A supplementation, retinol serum concentration may be low. As serum retinol does not reflect vitamin A status, evaluation of visual adaptation may be a more appropriate way to monitor for vitamin A deficiency in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11291950     DOI: 10.1023/a:1002793728087

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  28 in total

1.  Visual adaptation and the cone flicker electroretinogram.

Authors:  N S Peachey; K R Alexander; G A Fishman
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-04       Impact factor: 4.799

2.  Low plasma zinc concentrations in young infants with cystic fibrosis.

Authors:  N F Krebs; M Sontag; F J Accurso; K M Hambidge
Journal:  J Pediatr       Date:  1998-12       Impact factor: 4.406

3.  Factors that influence the increase in the electroretinogram 30-Hz flicker amplitude during light adaptation.

Authors:  K Raether; E Zrenner
Journal:  Ger J Ophthalmol       Date:  1996-09

4.  Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen.

Authors:  A P Feranchak; M K Sontag; J S Wagener; K B Hammond; F J Accurso; R J Sokol
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

5.  Vitamin A deficiency and dark adaptation in children.

Authors:  T A Zak
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

6.  Nyctalopia and conjunctival xerosis indicating vitamin A deficiency in cystic fibrosis.

Authors:  M A Neugebauer; S A Vernon; G Brimlow; J C Tyrrell; E J Hiller; C Marenah
Journal:  Eye (Lond)       Date:  1989       Impact factor: 3.775

7.  Loss of contrast sensitivity in cystic fibrosis.

Authors:  L E Leguire; K S Pappa; M L Kachmer; G L Rogers; D L Bremer
Journal:  Am J Ophthalmol       Date:  1991-04-15       Impact factor: 5.258

8.  Vitamin A deficiency and nocturnal vision in teenagers with cystic fibrosis.

Authors:  F Huet; D Semama; C Maingueneau; A Charavel; J L Nivelon
Journal:  Eur J Pediatr       Date:  1997-12       Impact factor: 3.183

Review 9.  Interactions between zinc and vitamin A: an update.

Authors:  P Christian; K P West
Journal:  Am J Clin Nutr       Date:  1998-08       Impact factor: 7.045

10.  Ocular findings in cystic fibrosis patients receiving vitamin A supplementation.

Authors:  J C Morkeberg; C Edmund; J U Prause; S Lanng; C Koch; K F Michaelsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

View more
  3 in total

Review 1.  Rapid recovery of night blindness due to obesity surgery after vitamin A repletion therapy.

Authors:  Y Spits; J-J De Laey; B P Leroy
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Xerophthalmia and acquired night blindness in a patient with a history of gastrointestinal neoplasia and normal serum vitamin A levels.

Authors:  Anastasios Anastasakis; Sotiris Plainis; Trisevgeni Giannakopoulou; Elisavet Papadimitraki; Charalambos Fanouriakis; Miltiadis K Tsilimbaris
Journal:  Doc Ophthalmol       Date:  2013-01-20       Impact factor: 2.379

3.  ERGs in children with pancreatic enzyme insufficient and pancreatic enzyme sufficient cystic fibrosis.

Authors:  Andrew Whatham; Catherine Suttle; Caron Blumenthal; Jane Allen; Kevin Gaskin
Journal:  Doc Ophthalmol       Date:  2009-03-03       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.